Showing results (451-460 of 744) with videos related to

Sort By:
Pageof 75
Pharmacotherapy|November 22, 2016
Clinical Experience with Daptomycin in PediatricsKatie C Namtu, Julianna C Crain, Allison F Messina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancerPeter Blume-Jensen, David M Berman, David L Rimm, et al.
Journal of Clinical Pharmacy and Therapeutics|November 9, 2020
Use of cidofovir with extracorporeal membrane oxygenation to treat adenovirus-associated acute respiratory distress syndrome in paediatric patients- a case seriesThao K Le, Brian K Brown, Katie C Namtu, et al.
Infection Control and Hospital Epidemiology|October 29, 2009
Healthcare worker knowledge of measurement and documentation of tuberculin skin test reactionScott H James, Juan A Dumois, Allison F Messina, et al.
The Journal of Urology|September 8, 2022
Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active SurveillanceClaire M de la Calle, Mufaddal M Mamawala, Patricia Landis, et al.
The American Journal of Surgical Pathology|June 14, 2019
Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF StatusSara E Wobker, Andres Matoso, Christine A Pratilas, et al.
The American Journal of Pathology|October 15, 2019
RNA Expression Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder Reveals a Basal-Like Molecular SubtypeUjjawal Manocha, Jordan Kardos, Sara Selitsky, et al.
The Journal of Urology|May 7, 2013
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillanceJeffrey J Tosoian, Eric JohnBull, Bruce J Trock, et al.
The American Journal of Surgical Pathology|September 25, 2013
GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladderCarla L Ellis, Alex G Chang, Ashley Cimino-Mathews, et al.
The Journal of Urology|November 21, 2017
Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active SurveillanceOudai Hassan, Misop Han, Amy Zhou, et al.
Pageof 75